What is the current stock price of Renaissance IPO ETF (IPO)?

As of the latest market data, Renaissance IPO ETF (IPO) is trading at $44.16. The stock has seen a gain of 1.45% today.

Does Renaissance IPO ETF (IPO) pay a dividend?

Based on current data, Renaissance IPO ETF does not have a confirmed active dividend policy.

What is the market cap of Renaissance IPO ETF?

The current market capitalization of Renaissance IPO ETF (IPO) is approximately unavailable.

IPO

Renaissance IPO ETF·Financial Services

44.16

1.447%(+0.63)

Market Closed

45.00

1.902%(+0.84)

After Hours

Last Updated: — ET

52W L: $34.1352W H: $54.68

IPO NEWS

proactiveinvestors.co.uk

Mar 30

IP Group launches Australian cleantech fund with clean energy body

IP Group PLC (LSE:IPO), the LSE-listed science and technology investor, has launched a new fund with Australia's Clean Energy Finance Corporation (CEFC) to back cleantech companies targeting hard-to-abate industries. The IP Group Climate Catalyst Fund has a target size of up to A$150 million, with IP Group contributing A$30 million and the CEFC A$20 million as cornerstone investors at first close.

seekingalpha.com

Mar 21

U.S. IPO Weekly Recap: REIT Carve-Out Sees Solid Demand While Drone Micro-Cap Soars 500%+

Three IPOs priced this past week, joined by two SPACs, and one major issuer joined the pipeline. One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for one company in the week ahead, and three lock-up periods will be expiring.

proactiveinvestors.co.uk

Mar 17

Here's why IP Group looks undervalued. Three brokers take a deep dive

Analysts at three brokerages maintain 'buy' ratings after strong full-year results IP Group PLC (LSE:IPO), the London-listed investor that commercialises intellectual property from leading universities, reported a 13% rise in net asset value (NAV) per share to 110.4p for the year ended December 2025, driven by a licensing deal tied to Pfizer's $10 billion acquisition of obesity drug developer Metsera. The company's shares rose 11% on Tuesday to 54.7p.

proactiveinvestors.co.uk

Mar 17

IP Group shares jump 9% as Metsera deal drives return to growth

Shares in IP Group PLC (LSE:IPO) rose 9% to 53.5p on Monday after the company reported net asset value per share climbing to 110.4p, with total NAV reaching £975.1 million. The recovery was driven largely by Pfizer's acquisition of Metsera, a biotechnology company developing obesity treatments.

benzinga.com

Mar 5

Roundhill Launches Space ETF Ahead of SpaceX IPO — One Holding Already Owns A Piece Of Musk's Rocket Company

Roundhill Investments has launched specialty ETFs focused on sectors such as sports betting, weight-loss drugs, autonomous vehicles and the metaverse.

proactiveinvestors.co.uk

Mar 4

IP Group portfolio company Oxa raises $103 million in Series D backed by National Wealth Fund and Nvidia

IP Group PLC (LSE:IPO), the London-listed science and technology investor, said portfolio company Oxa Autonomy has raised $103 million in the first close of a Series D funding round, backed by the UK's National Wealth Fund and NVentures, the venture capital arm of chip designer Nvidia. IP Group invested £7.5 million from its own balance sheet and a further £19 million through funds it manages on behalf of Australian pension fund Hostplus, giving it a combined beneficial holding of 20.3% in Oxa.

Company Profile

The fund seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the index. It normally invests at least 80% of its total assets in securities that comprise the index. The index is a portfolio of companies that have recently completed an initial public offering ("IPO") and are listed on a U.S. exchange. The fund is non-diversified.

Sector

Financial Services

Industry

Asset Management

IPO Date

2013-10-16

Beta

1.59